Werewolf Therapeutics annual total assets
2020
2021
2022
2023
2024
2025
Werewolf Therapeutics Total Assets Growth & History (HOWL)
Werewolf Therapeutics's total assets was $69.4M for fiscal 2025.
View full Werewolf Therapeutics company overviewWerewolf Therapeutics annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $69.4M | −$57.5M | −45.33% |
| 2024 | 2024-12-31 | $126.9M | −$47.9M | −27.40% |
| 2023 | 2023-12-31 | $174.8M | $14.6M | +9.10% |
| 2022 | 2022-12-31 | $160.2M | −$19.0M | −10.60% |
| 2021 | 2021-12-31 | $179.3M | $82.9M | +85.95% |
| 2020 | 2020-12-31 | $96.4M | — | — |
Werewolf Therapeutics quarterly total assets
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $24.2M | −$68.4M | −73.91% |
| Q1 2026 | 2026-03-31 | $58.0M | −$49.2M | −45.89% |
| Q4 2025 | 2025-12-31 | $69.4M | −$57.5M | −45.33% |
| Q3 2025 | 2025-09-30 | $79.6M | −$60.4M | −43.14% |
| Q2 2025 | 2025-06-30 | $92.6M | −$61.1M | −39.78% |
| Q1 2025 | 2025-03-31 | $107.2M | −$70.4M | −39.62% |
| Q4 2024 | 2024-12-31 | $126.9M | −$47.9M | −27.40% |
| Q3 2024 | 2024-09-30 | $140.0M | −$36.4M | −20.61% |
| Q2 2024 | 2024-06-30 | $153.7M | −$31.5M | −17.02% |
| Q1 2024 | 2024-03-31 | $177.6M | −$17.5M | −8.96% |
| Q4 2023 | 2023-12-31 | $174.8M | $14.6M | +9.10% |
| Q3 2023 | 2023-09-30 | $176.4M | $4.0M | +2.30% |
| Q2 2023 | 2023-06-30 | $185.2M | $9.9M | +5.65% |
| Q1 2023 | 2023-03-31 | $195.1M | $30.4M | +18.49% |
| Q4 2022 | 2022-12-31 | $160.2M | −$19.0M | −10.60% |
| Q3 2022 | 2022-09-30 | $172.4M | −$6.0M | −3.34% |
| Q2 2022 | 2022-06-30 | $175.3M | −$15.1M | −7.92% |
| Q1 2022 | 2022-03-31 | $164.6M | $75.2M | +84.08% |
| Q4 2021 | 2021-12-31 | $179.3M | $82.9M | +85.95% |
| Q3 2021 | 2021-09-30 | $178.4M | — | — |
| Q2 2021 | 2021-06-30 | $190.4M | — | — |
| Q1 2021 | 2021-03-31 | $89.4M | — | — |
| Q4 2020 | 2020-12-31 | $96.4M | — | — |
Werewolf Therapeutics total assets trends
Over the last five fiscal years, Werewolf Therapeutics's total assets decreased from $96.4M to $69.4M, a change of −$27.0M. The latest reported quarter, Q2 2026, shows $24.2M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Werewolf Therapeutics source filings ↗